QZW

Over-The-Counter Device To Assess Risk Of Sleep Apnea

Product code
QZW
Device name
Over-The-Counter Device To Assess Risk Of Sleep Apnea
Device class
Class 2
21 CFR
21 CFR 868.2378
Medical specialty
Anesthesiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
3
Summaries archived here
2 (direct download)
510(k) clearances (all years, FDA)
3 (all years; only the last 3 years are listed here)

FDA classification definition

An over-the-counter device to assess risk of sleep apnea is intended to provide a notification of the risk of sleep apnea in users who have not been previously diagnosed with sleep apnea. This device uses software algorithms to analyze input sensor signals and provide a risk assessment for sleep apnea. It is not intended to provide a standalone diagnosis, replace traditional methods of diagnosis (e.g., polysomnography), assist clinicians in diagnosing sleep disorders, or be used as an apnea monitor.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (3)

Last three years. Most recent: 2026-07-20.

NumberDecision dateApplicantDevice nameSummary
K2610112026-07-20Samsung Electronics Co., Ltd.Sleep Apnea Feature (v2.0)PDF
K2409292024-09-13Apple, Inc.Sleep Apnea Notification Feature (SANF)PDF
DEN2300412024-02-06Samsung Electronics Co., Ltd.Sleep Apnea Feature

2 summaries are archived here for direct download.

Official FDA classification page: QZW
Classification and pathway per current FDA publications. Data from openFDA (CC0).